William G. Kaelin, MD
Disclosures: Merck and Company, Inc.-Stocks, Stock Options, other Ownership Interest-I was on Peloton SAB, which was subsequently acquired by Merck. I could still receive additional milestone payments related to acquisition of Peloton triggered by MK-6482 approval and sales.|Eli Lilly and Company-Consulting Fee-Board Membership|Consulting Fee-Board Membership-LIfeMine Therapeutics|Consulting Fee-Advisory Committee-Circle Pharma|Stocks, Stock Options, other Ownership Interest-Cedilla Therapeutics-Founder|Stocks, Stock Options, other Ownership Interest-Tango Therapeutics-Founder|Consulting Fee-Advisory Committee-Nextech Invest|Consulting Fee-Advisory Committee-Fibrogen|Consulting Fee-Advisory Committee-Circle Pharma|Consulting Fee-Advisory Committee-Iconovir|Eli Lilly and Company-Stocks, Stock Options, other Ownership Interest-Abemaciclib (CDK4/6 Inhibitor)|Stocks, Stock Options, other Ownership Interest-Fibrogen-Roxadustat (HIF Stabilizer)- Royalty Agreement - 05/04/2021
No Bio Available.